...
首页> 外文期刊>Sensors and Actuators >SERS-based genetic assay for amplification-free detection of prostate cancer specific PCA3 mimic DNA
【24h】

SERS-based genetic assay for amplification-free detection of prostate cancer specific PCA3 mimic DNA

机译:基于SERS的遗传检测可无扩增检测前列腺癌特异性PCA3模拟DNA

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report the development of amplification-free surface-enhanced Raman scattering (SERS)-based DNA assays for the rapid and highly sensitive detection of prostate cancer antigen 3 (PCA3) mimic DNA. This technique does not require any DNA amplification process using thermo-cycles in conventional poly-merase chain reaction (PCR) due to its highly sensitive detection capability. Herein, the PCA3 mimic DNA, composed of 45 nucleotide sequences, was sandwiched between two probe DNA-immobilized particles (ASO_(735)-conjugated detection HGNs and ASO_(683)-immobilized capture magnetic beads) by hybridization reactions. Its quantitative analysis was performed by monitoring the characteristic Raman peak intensity of sandwich DNA complexes. The limit of detection (LOD) is estimated to be 2.7 fM, which is about four orders of magnitude more sensitive than that of conventional PCR. This SERS-based DNA assay technique is expected to be a potentially useful tool for early disease diagnosis.
机译:我们报告发展为基于快速,高灵敏度检测前列腺癌抗原3(PCA3)模拟DNA的无扩增的表面增强拉曼散射(SERS)为基础的DNA检测方法。这项技术由于具有高度灵敏的检测能力,因此不需要在常规的聚合酶链反应(PCR)中使用热循环的任何DNA扩增过程。在此,通过杂交反应,将由45个核苷酸序列组成的PCA3模拟DNA夹在两个固定有探针DNA的颗粒(固定有ASO_(735)的检测HGN和固定有ASO_(683)的捕获磁珠)之间。通过监测夹心DNA复合物的特征拉曼峰强度进行定量分析。检出限(LOD)估计为2.7 fM,比常规PCR灵敏度高出四个数量级。这种基于SERS的DNA测定技术有望成为早期疾病诊断的潜在有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号